At the same time, overexpression of PDCD2L promoted the activity of hepatocellular carcinoma cells while knockdown of BTF3 could partially reverse this trend (Figs. 4E, 5A, B). The gene discussed is PDCD2L; the disease is hepatocellular carcinoma.